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Abstract 
Dental pulp stem cells (DPSCs) are increasingly being recognized as a viable cell source for 
regenerative medicine.  However, significant heterogeneity in their ex vivo expansion 
capabilities are well-established, which influences their regenerative and therapeutic potentials.  
As highly proliferative/multi-potent DPSCs are minority sub-populations within dental pulp, the 
development of non-invasive strategies capable of successfully discriminating between DPSC 
sub-populations with contrasting proliferative and differentiation capabilities in situ, would be 
immensely beneficial for the selective screening/isolation of superior quality DPSCs for in vitro
assessment and therapy development.  Consequently, this study assessed the effectiveness of 
Single Cell Raman Spectroscopy (SCRM), in distinguishing between DPSC sub-populations 
with contrasting proliferative and differentiation capabilities isolated from dental pulp tissues.  
Individual DPSC sub-populations were isolated from human third molars and identified as high 
or low proliferative and multi-potent or uni-potent, following in vitro expansion and senescence 
confirmation.  High proliferative/multi-potent DPSCs, such as A3 (18PDs and 60PDs) and low 
proliferative/uni-potent DPSCs, including A1 and B1 (8PDs and 7PDs respectively), were 
analysed using an iHR550 Raman Spectrometer, equipped with a CCD camera and Eclipse Ti-
U Inverted Microscope.  Single cell spectra were acquired for 20 cells in each sub-population 
(10 spectra per nuclear and 10 spectra per cytoplasmic/membrane regions in each cell analys d), 
over 500-2100 cm-1.  Spectra and peak assignments were obtained, followed by PCA and 
multivariate statistical analysis.  Although DPSC spectra contained typical Raman peaks for 
nucleic acids, proteins and lipids, the spectral intensities of high proliferative/multi-potent 
DPSCs, A3 (18PDs), were higher than A3 (60PDs), A1 (8PDs) and B1 (7PDs), reflecting 
significantly elevated DNA (729 cm-1) and protein (1111, 1167, 1245 and 1680 cm-1) contents 
overall.  PCA and multivariate analysis revealed significant variations in scatter plots and Raman 
signatures, with distinct fingerprints for high proliferative/multi-potent DPSCs, A3 at 18PDs and 
60PDs; versus the similar overlapping profiles for low proliferative/uni-potent DPSCs, A1 
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(8PDs) and B1 (7PDs).  This study confirms that SCRM successfully discriminates between 
DPSC sub-populations with contrasting proliferative and differentiation capabilities, advocating 
its further assessment as a viable technique for the selective non-invasive screening, 
identification and isolation of high proliferative/multi-potent DPSCs from dental pulp tissues for 
regenerative medicine applications. 
 
Impact Statement 
This study is the first to investigate and confirm the effectiveness of Single Cell Raman 
Spectroscopy (SCRM), in its ability to discriminate between DPSCs with contrasting 
proliferative and differentiation capabilities.  The findings show that SCRM can rapidly and non-
invasively distinguish and identify DPSC sub-populations in vitro with superior proliferative and 
multi-potency properties, versus lesser quality DPSCs; thereby overcoming the significant 
heterogeneity issues surrounding DPSC ex vivo expansion and differentiation capabilities.  Such 
findings support further SCRM assessment for the selective screening/isolation of superior 
quality DPSCs from whole dental pulp tissues, for more effective in itro evaluation and therapy 
development. 
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Introduction 
Tissue repair and regeneration in patients with chronic diseases are a major clinical challenge, 
especially with ever-increasing ageing populations worldwide.  Adult mesenchymal stem cells 
(MSCs) are vital to tissue engineering for the development of cell-based therapies.  Dental pulp 
stem cells (DPSCs) are increasingly recognized as a viable stem cell source for regene ative 
medicine purposes, due to their self-renewal, clonogenicity and multi-potent differentiation 
properties.1-4  However, similar to bone marrow-derived MSCs, DPSCs possess significant 
heterogeneity, with individual clones demonstrating differences in proliferation and lineage 
differentiation capabilities.  Indeed, despite heterogeneous DPSC population expansion 
achieving >120 population doublings (PDs) in vitro, only 20% of purified DPSCs are capable of 
proliferating >20PDs.  Of these, only two-thirds generated ectopic dentine i  vivo, implying that 
subset DPSC populations differ in their regenerative potentials.5-6 
DPSCs are also proposed to exist within distinct niches within dental pulp tissues (sub-
odontoblast layer, pulpal vasculature and central pulp),7 which increases the complex nature of 
the origins and regenerative characteristics of individual DPSC sub-populations further.  Such 
considerations are pivotal to the exploitation of DPSCs, as a significant limitation of MSC-based 
therapies is that extensive in vitro expansion eventually leads to proliferative decline and 
senescence, accompanied by impaired cellular regenerative properties.8-10  Despite significant 
differences in the ex vivo expansion capabilities of individual DPSCs being recognized, only 
recently has work begun to address the impact of such variations in proliferative capabilities 
prior to senescence, on the multi-potency of different DPSC sub-populations.11  Although high 
proliferative DPSCs achieved >80PDs, low proliferating DPSCs only completed <40PDs before 
senescence, correlating with DPSCs with high proliferative capacities possessing longer 
telomeres (>18 kb) than less proliferative populations (5-13 kb).  Low proliferative DPSC 
senescence was also associated with early loss of stem cell marker characteristics and impaired 
osteogenic and chondrogenic differentiation, in favour of adipogenesis.  In contrast, high 
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proliferative DPSCs retained multi-potent differentiation capabilities, only demonstrating 
impaired differentiation following prolonged in vitro expansion (>60PDs).11 
 It has been proposed that high proliferative/multi-potent DPSCs are minority sub-
populations within dental pulp tissues.7, 11  Therefore, in order to fully exploit these desirable 
DPSCs for regenerative purposes, it is imperative that strategies are developed which permit the 
optimisation of population selection through the selectively screening and isolation of superior 
quality DPSCs from dental pulp tissues for in vitro expansion, assessment and prudent cell 
banking; thereby aiding the translational development of more effective DPSC-based therapies 
for clinical evaluation and application.12-14  However, conventional ex vivo cellular expansion 
and stem cell/senescence characterisation techniques used to identify superior DPSCs are often 
expensive, labour-intensive and time-consuming; whilst cellular expansion can also 
detrimentally alter stem cell characteristics leading to reduced regenerative properties.11, 15  Such 
issues may be confounded by the requirement for invasive fixation, staining or cell 
permeabilisation techniques, which damage cellular components during MSC 
characteristation.15-18  Furthermore, these procedures prevent the reuse of evaluated cells, while 
many techniques utilised have resolution limitations and thus, cannot be performed at single cell 
levels.  Consequently, there is a need to develop more non-destructive approaches to cell 
imaging, analysis and identification i situ, to provide highly sensitive real-time imaging and 
chemical information during cell characterisation; ultimately leading to the more effective use 
of MSCs for regenerative therapies. 
Raman Spectroscopy is increasingly becoming a powerful analytical method in 
biomedical research, particularly due to its label-free and non-invasive characteristics.  Raman 
Spectroscopy is a laser-based scattering technique, which permits the analysis of cellular 
chemical composition (DNA, RNA, lipids, proteins), molecular markers and the biological 
functions of individual cells within a spectral region of 600-2000 cm-1; through the use of 
Principal Component Analysis (PCA) and multivariate statistical analysis.19-20  Consequently, 
6 
 
Raman spectra obtained for individual cells provide unique biochemical fingerprints of cellular 
status and functions, including metabolism, phenotype, apoptosis/senescence; and abilities to 
distinguish between different cell types.  Raman Spectroscopy is now widely used in 
regenerative medicine for the characterisation of multi-potency/pluri-potency and the 
differentiation status of MSCs from numerous sources, including dental pulp.16-18, 21-23  However, 
this proof-of-concept study is the first to apply Single Cell Raman Spectroscopy (SCRM) to 
DPSC sub-populations to evaluate its abilities in providing real-time evidence capable of 
discriminating between DPSCs with contrasting proliferative and differentiation capabilities ex 
vivo.  Successful validation will subsequently form the basis for the further assessment of SCRM 
for the identification and isolation of high proliferative/multi-potent DPSCs from intact dental 
pulp tissues in situ, for regenerative medicine purposes. 
 
Materials and Methods 
Dental pulp stem cell isolation and characterisation of proliferation/differentiation capabilities 
DPSCs were isolated from third molar teeth collected from patients (all female, age 18-30 years), 
with informed patient consent and ethical approval, as previously described.11  Single cell 
suspensions of dental pulp tissues were obtained, with DPSCs preferentially selected and isolated 
from cell suspensions by differential fibronectin adhesion assay.11, 24  Isolated cells were 
confirmed as DPSCs through cell surface marker expression (positive for MSC markers, CD73, 
CD90 and CD105; negative for hematopoietic stem cell marker, CD45).  DPSCs subsequently 
underwent extended culture expansion and characterisation as being high or low proliferative 
and multi- or uni-potent.  Proliferation analysis was based on the PDs reached by each DPSC 
sub-population prior to senescence (at <0.5PDs/week); and the detection of other senescence-
related markers, including reduced telomere lengths, positive senescence-associated β-
galactosidase staining; and increased p53, p21waf1 and p16INK4a expression.11  Differentiation 
analyses were based on the abilities of each DPSC sub-population to undergo osteogenic, 
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chondrogenic and adipogenic differentiation, via detection of established differentiation markers 
as previously described.11  Individual DPSC sub-populations were subsequently confirmed as 
being high proliferative/multi-potent DPSCs (such as A3, capable of >80PDs) or low 
proliferative/uni-potent DPSCs (such as A1 and B1, capable of <40PDs).11 
 
Raman Spectroscopy instrumentation 
The Raman Microscopy system used in this study is shown in Fig. 1.  The instrument was based 
on an Eclipse Ti-U Inverted Microscope, with a 20x (NA = 0.75) dry objective (Nikon, Kingston 
upon Thames, UK).  The laser source was a Diode Pumped Solid-State Laser, operating at 532 
nm and maximum power of 50 mW (Lasever, Ningbo, China).  The laser beam passed through 
a Semrock Clean-up Filter (Laser 2000, Huntington, UK), to remove optical noise. To fulfil the 
back-aperture (diameter, 4.37 mm) of the 20x objective, the laser beam size (1/e2) of 2 mm was 
expanded x3.  At this size, a 1:3 beam expander composed of two visible achromatic lenses of 
focal lengths, f = +75 mm and f = -25 mm, were used with a scan lens of f = 100 mm (all 
Thorlabs, Ely, UK). 
The laser beam was reflected from a Semrock Dichroic Beam Splitter (Laser 2000) and 
focused onto each sample by the objective lens.  Raman scattered light was collected by the 
objective lens and transmitted via the same Dichroic Beam Splitter.  Scattered light passed 
through a Steinheil Triplet Achromatic Lens (1:1 magnification, f = 50 mm, Edmund Optics, 
York, UK); followed by a 6mm Confocal Slit (Thorlabs) and another Triplet Achromatic Lens.  
A bi-convex lens (f = 25 mm, Thorlabs) was placed in front of the Confocal Slit to image samples 
onto the grating of the spectrometer.  Before entering the Spectrometer, Raman scattered light 
passed through a Semrock Long Pass Filter (Laser 2000), to reject Rayleigh scatter. 
The spectrometer used was an iHR550 Jobin Yvon Imaging Spectrophotometer (Horiba, 
Kyoto, Japan), equipped with a 600 grooves/mm grating (spectral resolution, 4 cm-1) and Newton 
940 Spectroscopy CCD Camera (Andor Technology, Belfast, UK).  The spectrometer was 
8 
 
calibrated prior to each experiment, using a clear Neon Lamp (RS Components, Corby, UK), 
which allowed Raman spectra pixel conversion to wavenumbers.  Neon spectra were taken at 
central wavelength positions of 600 nm.  Neon spectra in pixels were compared with published 
neon spectra in wavelength format; and pixel-wavelength experimental data plotted using linear 
regression.  Detector sensitivity was determined to be ~98%. 
 
Sample preparation and Single Cell Raman Spectroscopy analysis 
High proliferative/multi-potent DPSC sub-population, A3, at early (18PDs) and late (60PDs) 
stages in their proliferative lifespans; and low proliferative/uni-potent DPSCs, A1 and B1 (8PDs 
and 7PDs, respectively); were cultured in T-75 flasks until 80% confluence and harvested using 
StemPro®Accutase® (ThermoFisher Scientific, Paisley, UK).  Cells were retrieved, washed (x2) 
in phosphate buffered saline and fixed in 96% alcohol, at 2.5x105 cells/mL.  Sample chambers 
were made using 80 µm deep vinyl spacers between quartz slides and coverslips (1 mm and 200 
μm thickness, respectively; UQG, Cambridge, UK).  DPSC suspensions (5x103 cells, 20 μL) 
were pipetted directly onto the quartz surfaces and DPSCs allowed to sediment onto the inverted 
coverslips for ∼30 min, prior to analysis.  SCRM spectra were acquired from 20 fixed cells from 
each DPSC sub-population, along with the background spectra.  The laser power on each sample 
during signal acquisition was ∼36 mW; and each spectrum was collected in the range from 500-
2100 cm−1 (grating 150 grooves/mm) with an integration time of 60 s.  At the beginning of each 
Raman session, the dark current of the Andor CCD camera was also quantified.  Ten spectra 
were measured for the nuclear and ten for the cytoplasmic/membrane regions of each cell 
analysed, to obtain average spectra representative of each DPSC sub-population analysed. 
 
Single Cell Raman Spectroscopy data analysis 
Raw data were converted into Raman spectra using Origin V7 Software (OriginLab, 
Northampton, USA).  Mean Raman and background spectra derived from the 20 individual cells, 
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were collected and dark currents subtracted.  Average backgrounds were subtracted from each 
mean Raman spectrum for fluorescence suppression.25  All spectra were normalised to peak areas 
at 1450 cm-1 (related to C-H deformation vibrations in nucleic acids, proteins, carbohydrates and 
lipids), to enable direct data comparisons26.  Data were detected as relative intensities (arbitrary 
units, a.u.), with the main Raman spectra peaks for each DPSC sub-population assigned through 
comparisons to previously described reference peaks.16, 27-28  Raman spectra were further 
analysed using PCA and multivariate statistical analysis, with principal components (PC) scores 
reflecting the most significant variations in DPSC Raman spectra.  PC analysis was performed 
using built-in R function, prcomp. 
 
Statistical analysis 
The peak intensities of selected bands for the high proliferative/multi-potent and low 
proliferative/uni-potent DPSCs, were expressed as mean±standard deviation of the mean (SD).  
Statistical analysis was performed using Prism Software (GraphPad Software, San Diego, USA), 
with statistical significance between selected Raman peaks confirmed by unpaired Student’s t 
tests.  Significance was considered at p<0.05. 
 
Results 
Discrimination between dental pulp stem cells with contrasting proliferative/differentiation 
capabilities 
Distinct DPSC sub-populations were previously isolated and characterised as high 
proliferative/multi-potent (A3) and low proliferative/uni-potent (A1 and B1).11  DPSCs were 
subsequently analysed to confirm whether SCRM could distinguish between such sub-
populations with contrasting proliferative and differentiation capabilities n vitro, based on the 
respective Raman spectra and molecular fingerprints obtained. 
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Mean Raman spectra obtained over 600-1800 cm-1, for particular high 
proliferative/multi-potent and low proliferative/uni-potent DPSC sub-populations at specific 
PDs, are shown in Fig. 2.  The dominant peaks and corresponding assignments identified within 
these Raman spectra, are presented in Table 1.  Spectra for high proliferative/multi-potent DPSC 
sub-population, A3, at early (18PDs) and late (60PDs) stages in their proliferative lifespans; and 
low proliferative/uni-potent DPSCs, A1 and B1 (8PDs and 7PDs, respectively), were identified 
to contain typical Raman peaks for biomolecules, including DNA and proteins, in addition to the 
expected detection of C-H deformation vibrations in nucleic acids, proteins, carbohydrates and 
lipids at 1450 cm-1; consistent with reports with various other cell types.15-16, 27-28  Specifically, 
Raman bands associated with DNA bases at 729 cm-1 (ring breathing of adenine) and 765 cm-1 
(pyrimidine ring breathing mode); and the nucleic acid backbone at 789 and 1092 cm-1 (β-
conformation DNA and PO2- phosphodiester stretching vibrations) were identified.  Similarly, 
Raman protein bands were detected at 834, 858, 1167, 1245, 1402, 1629 and 1680 cm-1, 
accounting for tyrosine, isoleucine, amide III, Cβ rocking (arginine), serine and amide I regions, 
respectively.  Regions 1-5 denote the largest peaks detected (Fig. 2 and Table 1, bracketed 
regions).  However, spectral differences were particularly evident when comparing high 
proliferative/multi-potent DPSC sub-population, A3 at 18PDs, versus A3 at 60PDs and the low 
proliferative/uni-potent sub-populations, A1 (8PDs) and B1 (7PDs).  Indeed, the spectral 
intensities of A3 (18PDs) were much higher than A3 (60PDs), A1 (8PDs) and B1 (7PDs), 
reflecting elevated DNA and protein contents overall.  Furthermore, peaks for RNA ribose C-O 
vibration (1054 cm-1) were only identifiable for high proliferative/multi-potent sub-population, 
A3 (18PDs, Fig. 2 and shaded region, Table 1).  Other notable variations identified included the 
increased detection of benzoid ring deformation (1111 cm-1) with high proliferative/multi-potent 
sub-population, A3 (18PDs) only; and phenylalanine peaks (958 cm-1) with high 
proliferative/multi-potent sub-population, A3, at both 18PDs and 60PDs only.  Sub-population 
differences in other amino acid and protein levels were also detected, with the absence of peaks 
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relating to C-C/C-N protein stretching (1155 cm-1) and tyrosine (1614 cm-1), with low 
proliferative/uni-potent sub-population, B1 (7PDs, Fig. 2 and sha ed regions, Table 1). 
 
Raman peak intensity differences related to cell proliferation and growth 
To further illustrate spectral differences between DPSC sub-populations, the peak intensity 
differences in selected DNA and protein bands associated with cellular proliferation/growth, 
were assessed between high proliferative/multi-potent sub-population, A3 at 18PDs and 60PDs, 
compared to low proliferative/uni-potent sub-populations, A1 (8PDs) and B1 (7PDs, in bold, 
Table 2).  In line with their more proliferative nature, DPSC sub-population, A3 (18PDs), 
exhibited higher DNA (729, 786 and 1092 cm-1) and protein (1167, 1245, 1629 and 1680 cm-1) 
peak intensities, particularly versus both low proliferative/uni-potent sub-populations, A1 
(8PDs) and B1 (7PDs, Table 2).  Such peak intensity differences were most prominent for 
reductions in DNA (729, 789 and 1092 cm-1) and C-H deformation vibrations (1450 cm-1) in the 
low proliferative/uni-potent sub-populations, with peak intensity reductions even being of 
greater magnitude than those for high proliferative/multi-potent sub-population, A3 (60PDs).  In 
contrast, high proliferative/multi-potent sub-population, A3 (60PDs), exhibited more subtle 
differences in peak intensities, versus their early PD counterparts (Table 2).  However, A3 
(60PDs) and low proliferative/uni-potent sub-populations, A1 (8PDs) and B1 (7PDs), all 
exhibited major decreases in protein-related peak intensities at 1167 cm-1 (isoleucine), 1245 cm-
1 (amide III region), 1402 cm-1 (Cβ rocking, arginine), 1629 cm-1 (serine); and 1680 cm-1 (amide 
I region), compared to high proliferative/multi-potent, A3 (18PDs, Table 2). 
 Peak intensity differences between high proliferative A3 (18PDs) and low proliferative 
A1 (8PDs) and B1 (7PDs) were confirmed to be statistically significant for DNA (729 cm-1, both 
p<0.001) and protein (1167, 1245 and 1680 cm-1, p<0.001-p<0.05) peaks (Fig. 3).  However, no 
significant differences were shown between A3 (18PDs) and both low proliferative/uni-potent 
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sub-populations, A1 (8PDs) and B1 (7PDs), for DNA peaks at 786 and 1092 cm-1; and protein 
peaks at 1629 cm-1 (all p>0.05). 
 
PCA discrimination between dental pulp stem cells with contrasting proliferative and 
differentiation capabilities 
Further analysis of high proliferative/multi-potent and low proliferative/uni-potent DPSC Raman 
spectra using PCA and multivariate statistical analysis, revealed spectral discrimination between
DPSC sub-populations.  This was particularly evident with the loading plots for principle 
components, PC3 and PC4, which provided the largest variance (PC3 = 98%, PC4 = 97%), 
between DPSC sub-population spectra (Fig. 4).  2D scatter plot obtained using PC3 and PC4 
scores for high proliferative/multi-potent DPSC sub-population, A3, at 18PDs and 60PDs; and 
low proliferative/uni-potent DPSCs, A1 and B1 (8PDs and 7PDs, respectively); are shown in 
Fig. 5.  The scatter plots demonstrated clear spatial separation between the profiles obtained for 
each DPSC sub-population, with three clearly distinct clusters evident.  Furthermore, the 
compact nature of individual clusters indicated high levels of homogeneity within each dataset.  
These clusters were particularly representative of high proliferative/multi-potent DPSC, A3 
(18PDs, in blue) and (60PDs, in orange); and the low proliferative/uni-potent DPSCs, A1 and 
B1 (8PDs and 7PDs, in red and green, respectively).  The clusters for both low proliferative/uni-
potent DPSCs, A1 (8PDs) and B1 (7PDs) showed almost complete overlap indicative of high 
Raman signature similarity.  In contrast, profiles for the high proliferative/multi-potent DPSC, 
A3 (at 18PDs and 60PDs), were distinctly dissimilar to those for A1 (8PDs) and B1 (7PDs), as 
these exhibited well separated signatures with no A1 or B1 cluster overlap.  Furthermore, despite 
being derived from the same DPSC sub-population, both A3 profiles did not exhibit any overlap 
when compared at early (18PDs) and late (60PDs) stages in their proliferative lifespans, 
indicative of large variations in DPSC sub-population signatures overall. 
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Discussion 
The present study describes a novel investigation, confirming the abilities of SCRM to non-
invasively discriminate between DPSC sub-populations with contrasting proliferative and 
differentiation capabilities.  The results obtained also provide unique insight into the biochemical 
differences which exist between non-senescent and senescent DPSC sub-populations. 
Previous reports have demonstrated that only 20% of purified DPSCs undergo >20PDs, 
compared with heterogeneous DPSC populations (>120PDs), highlighting the presence of DPSC 
sub-populations in dental pulp tissues with contrasting proliferative and differentiation 
capabilities.5-7  Consistent with such findings, recent studies have reported key differences 
between DPSC sub-populations in the relative susceptibilities to replicative (telomere-
dependent) senescence, correlating with contrasting differentiation capabilities within each 
population.11  Whilst highly proliferative DPSCs, A3, reached >80PDs before undergoing 
senescence, low proliferative DPSCs, A1 and B1, only achieved <40PDs.  Unlike low 
proliferative DPSCs, highly proliferative DPSCs retained stem cell marker expression and multi-
potent differentiation capabilities, which were only impaired at much later PDs (>60PDs).  
Therefore, it has been proposed that such high proliferative DPSCs are responsible for the 
extensive expansion potential of heterogeneous populations (>120PDs) in vitro,5-6 as less 
proliferative, uni-potent DPSCs would be selectively lost from the mixed populations during 
extended sub-culture.11, 24 
 From the findings reported, it is evident that such phenotypic differences in DPSC sub-
population proliferative and regenerative capabilities can be rapidly and sensitively distinguished 
using SCRM, given the contrasting Raman fingerprints obtained for high proliferative/multi-
potent and low proliferative/uni-potent DPSCs as a consequence of distinct differences in the 
biochemical (DNA, RNA, protein, lipid) compositions of these cells overall.  Such conclusions 
also reiterate the significant variations in the biological status and reparative properties of these 
DPSC sub-populations.11  Although Raman Spectroscopy has been used extensively in MSC 
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research, studies have primarily focussed on its application to distinguish MSC populations from 
non-somatic cells; and the assessment of differentiation status in MSCs from various sources.16-
18, 21-23  However, concurrent with its successful utilisation in the present study to discriminate 
between high proliferative/multi-potent and low proliferative/uni-potent DPSCs, Raman 
Spectroscopy has recently been shown to distinguish between proliferative/non-proliferative, 
senescent/non-senescent, young/aged and viable/non-viable cells, within other MSC and 
fibroblast populations.15, 29-33 
 The increased spectral intensities obtained for high proliferative/multi-potent DPSC sub-
population, A3 (18PDs), compared to more senescent A3 (60PDs) and to low proliferative/uni-
potent DPSCs, A1 and B1 (8PDs and 7PDs, respectively), are consistent with recent studies 
reporting alterations in the biomolecular compositions of senescent fibroblast populations, 
versus non-senescent counterparts; relating to band intensities and/or band positions.31-32  
Specifically, such studies have associated reductions in DNA (788, 1580 cm-1) and protein (1658 
cm-1) peaks, in addition to elevated lipid (1732, 2850 and 2930 cm-1) peak contents during 
cellular senescence, with protein and lipid modifications predominating overall.31-32  Amide I 
peak intensities have been demonstrated to be particularly sensitive to conformational changes 
during senescence, whilst distinct amide III region changes having also been reported.31-32  
Changes in the ratio of 1157 cm-1 (C-C/C-N protein stretching) and 1174 cm-1 (C-H bending 
vibrations in phenylalanine and tyrosine) due to reduced 1157 cm-1 peak intensities, have further 
been proposed as characteristic signatures of umbilical cord-derived, MSC senescence.15  
However, despite senescence-induced shifts in lipid conformation (2850 cm-1) having been 
assigned to the CH2 symmetric stretch of lipids,31 no such changes were evident herein, as SCRM 
spectra were recorded over 600-1800 cm-1. 
From the assignments and the peak intensities identified, it was apparent that such 
differences reflected elevations in DNA (729, 786, 1092 and 1450 cm-1) and protein (1167, 1245, 
1402, 1450, 1629 and 1680 cm-1) contents in non-senescent, high proliferative/multi-potent 
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DPSC, A3 (18PDs).  Such peak intensity increases were particularly significant for A3 (18PDs), 
at 729 cm-1 (ring breathing of adenine), 1111 cm-1 (benzoid ring deformation), 1167 cm-1 
(isoleucine), 1245 cm-1 (amide III region), and 1680 cm-1 (amide I region).  Additionally, sub-
population differences in other amino acid and protein contents were also detected, including 
increased 958 cm-1 (phenylalanine) peaks in high proliferative/multi-potent sub-population, A3, 
at 18-60PDs and 60PDs, respectively; in addition to reduced 1155 cm-1 (C-C/C-N protein 
stretching) and 1614 cm-1 (tyrosine) peaks with low proliferative/uni-potent sub-population, B1 
(7PDs) only.  As DNA, amino acids and proteins are fundamental biochemical constituents 
which facilitate cellular responses, contrasting intensities in these peaks are consistent with the 
proliferative and differentiation capabilities of high and low DPSC sub-populations overall.11, 15, 
31-34  Therefore, as Raman signature changes during senescence are proposed to be principally 
caused by biomolecular modifications to proteins and lipids, rather than changes in molecular 
abundance,31 the present findings are partly counterintuitive to such findings, considering the 
considerable reductions in biomolecular abundance evident herein.15  However, the particular 
predominance of amino acid/protein peak intensity changes between high/multi-potent and low 
proliferative/uni-potent DPSCs, concurs with previous reports.15, 31-32 
Senescence-induced biomolecular modifications are strongly linked with oxidative 
stress, due to elevated reactive oxygen species (ROS) production by senescent cells causing 
accumulative damage to cellular components.8, 35-36  Although DNA is a strong candidate for 
oxidative modification, proteins and lipids are also highly susceptible to oxidative stress-
induced, damage.37-39  Indeed, protein oxidation by ROS is mediated via amino acid 
modification, leading to increased cross-linking, aggregation and cleavage; which subsequently 
influence protein structure and function.40-41  ROS modification of amino acids results in the 
formation of numerous oxidised by-products, although many aromatic (phenylalanine, tyrosine) 
and non-aromatic (proline, histidine, lysine, arginine, serine) amino acids are known to be highly 
susceptible to ROS modification.40-41  Thus, it is conceivable that reductions in phenylalanine 
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(958 cm-1), benzoid ring deformation (1111 cm-1), arginine (1402 cm-1), tyrosine (1614 cm-1) 
and serine (1629 cm-1) peaks in low proliferative/uni-potent DPSCs (A1, 8PDs; B1, 7PDs), are 
consequences of increased oxidative modification o these amino acids in low proliferative 
(senescent) sub-populations; leading to subsequent reductions in protein band detection (1155, 
1245 and 1680 cm-1).  Consequently, the spectral differences identified overall may be attributed 
to alterations in the quantities of certain biomolecular species between high/multi-potent and low 
proliferative/uni-potent DPSC sub-populations, in addition to conformational changes in protein, 
DNA, and lipid structures due to oxidative stress.15, 31-32 
 PCA analysis was further capable of discriminating between high proliferative/multi-
potent DPSCs (A3, 18PDs) and the similarly overlapping clusters of low proliferative/uni-potent 
DPSCs, A1 (8PDs) and B1 (7PDs), coinciding with the proliferative and differentiation 
heterogeneity of DPSC sub-populations previously described.11  In particular, PC3 and PC4 
components showed significant cluster separation between highly proliferative DPSC, A3, at 
early (18PDs) and late (60PDs) stages in their proliferative life-spans.  As previous studies have 
also identified significant spatial separation between the scatter plots of non-senescent and 
senescent cell populations,31-32 obvious differences between the clusters for high (A3, 18PDs) 
and low proliferative/uni-potent DPSCs, A1 (8PDs) and B1 (7PDs) were shown, despite A1 and 
B1 being derived from different patient donors.  As with the apparent DNA and protein peak 
intensity differences identified between the same DPSC sub-population, A3, at 18PDs and 
60PDs; similar non-overlapping cluster differences were also observed.  However, the A3 
(60PDs) cluster remained well-separated from the clusters for low proliferative/uni-potent 
DPSCs, A1 (8PDs) and B1 (7PDs), with no overlap evident.  Such variations in the A3 (60PDs) 
signatures to those of A3 (18PDs) and A1 (8PDs)/B1 (7PDs), may be interpreted as the detection 
of increased A3 transition from proliferation (18PDs) towards senescence (60PDs), although the 
A3 (60PDs) signatures had yet reached the equivalent senescence status displayed by A1 (8PDs) 
and B1 (7PDs).  Indeed, despite good cluster separation between young and senescent cells, 
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previous studies have further shown cluster overlap during senescence transition at intermediate 
PDs, indicating non-linear signature/peak intensity changes and individual cell heterogeneity 
within a population during senescence transition.15, 31-32  However, we can only speculate on the 
underlying reasons for such differences in the cluster profiles and proliferative/differentiation 
responses between DPSC sub-populations at present, as intrinsic factors, such as those associated 
with patient donor characteristics, and/or the developmental origins and stem cell niche sources 
of these DPSC sub-populations within pulpal tissues, warrant additional consideration.5-7, 11 
Nonetheless, this study shows that SCRM can successfully and reliably discriminate 
between high proliferative/multi-potent and low proliferative/uni-potent DPSCs, with clear 
differences in biochemical signatures between these distinct DPSC sub-populations.  Therefore, 
concomitant with their established heterogeneous proliferative and regenerative properties,5-6, 11 
such contrasting SCRM profiles reflect the high proliferative/multi-potent nature of certain 
DPSCs, evident by their increased DNA/protein contents and the prevalence of particular DNA 
and protein signature peaks, compared to low proliferative/uni-potent DPSCs.  As these signature 
differences may reflect similarly contrasting proliferative and differentiation characteristics 
between DPSC sub-populations in vivo, this study advocates further SCRM assessment as a 
viable tool for the selective screening and isolation of desirable high proliferative/multi-potent 
DPSCs from dental pulp tissues for regenerative medicine applications. 
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Figure Legends 
FIG. 1.  Schematic diagram of the Raman Microscopy set-up used in this study. 
FIG. 2.  Comparison of mean Raman spectral fingerprints for high proliferative/multi-potent 
DPSC sub-population, A3 at 18PDs and 60PDs; and low proliferative/uni-potent DPSC sub-
populations, A1 and B1 (8PDs and 7PDs, respectively).  Mean spectra were determined from 
n=20 individual cells per DPSC sub-population and displayed in the fingerprint range of 600-
1800 cm-1.  Spectra were normalised to peak areas at 1450 cm-1. Data were detected as relative 
intensities (arbitrary units, a.u.).  The most prominent spectral bands are highlighted (n blue) 
and the corresponding wavenumbers assigned.  Regions 1-5 denote the largest peaks detected.  
All spectra contained typical Raman peaks for DNA (729, 765, 789 and 1092 cm-1), proteins 
(834, 858, 1167, 1245, 1402, 1629 and 1680 cm-1) and biomolecular C-H deformation vibrations 
(1450 cm-1).  The spectral intensity of A3 at 18PDs were much higher than A3 (60PDs), A1 
(8PDs) and B1 (7PDs), reflecting elevated DNA and protein contents overall.  Certain peaks 
were particularly identifiable in high proliferative/multi-potent sub-population, A3, at 18PDs 
(see Table 1 for further details). 
FIG. 3.  Mean peak intensities for selected DNA (729, 789 and 1092 cm-1) and protein (1167, 
1245, 1629 and 1680 cm-1) bands commonly associated with cellular proliferation/growth, 
detected in Raman spectra of high proliferative/multi-potent DPSC sub-population, A3 (18PDs); 
and low proliferative/uni-potent DPSC sub-populations, A1 and B1 (8PDs and 7PDs, 
respectively).  Peak intensity data were presented as arbitrary units (a.u.).  Statistically significant 
increases in peak intensities were shown for DNA (729 cm-1, p<0.001) and protein (1167, 1245 
and 1680 cm-1, p<0.001-p<0.05) peaks, in high proliferative/multi-potent DPSC sub-population, 
A3 (18PDs).  No other significant differences were shown (p>0.05).  Peak intensity values were 
determined from n=20 individual cells per DPSC sub-population, with data expressed as 
mean±SD (*p<0.05, **p<0.01 and ***p<0.001). 
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FIG. 4.  Principle Component Analysis (PCA) loading plots for (A) PC3 and (B) PC4, which 
provided the largest variance and spectral discrimination between high proliferative/multi-potent 
DPSC sub-population, A3 at 18PDs and 60PDs; and low proliferative/uni-potent DPSC sub-
populations, A1 and B1 (8PDs and 7PDs, respectively).  Extent of variation data were presented 
as arbitrary units (a.u.). 
FIG. 5.  Principle Component Analysis (PCA) 2D scatter plots obtained using PC3 and PC4 
scores for individual Raman spectra for high proliferative/multi-potent DPSC sub-population, 
A3, at 18PDs and 60PDs; and low proliferative/uni-potent DPSC sub-populations, A1 and B1 
(8PDs and 7PDs, respectively).  Scatter plot demonstrated widespread differences between 
DPSC sub-population profiles, with three distinct Raman clusters evident for high 
proliferative/multi-potent DPSC, A3 at 18PDs (in blue), A3 at 60PDs (in orange); and low 
proliferative/uni-potent DPSCs, A1 and B1 at 8PDs and 7PDs (in red and green, respectively).  
Low proliferative/uni-potent DPSC clusters exhibited almost complete overlap, indicative of 
high signature similarity.  Profiles for the high proliferative/multi-potent DPSC, A3 (18PDs) and 
(60PDs), were distinctly dissimilar to each other and to those for A1 (8PDs) and B1 (7PDs), 
indicative of large Raman signature differences overall.  Spectra were determined from n=20 
individual cells per DPSC sub-population. 
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Table 1.  Dominant peaks and their corresponding assignments,16, 27-28 identified in mean Raman 
spectra for high proliferative/multi-potent DPSC sub-population, A3 at 18PDs and 60PDs; and 
low proliferative/uni-potent DPSC sub-populations, A1 and B1, (8PDs and 7PDs, respectively).  
Regions 1-5 (in bold) denote the largest detectable peaks.  Shaded areas indicate peaks 
demonstrating the largest differences between DPSC sub-populations. 
 
Wavenumber 
(cm-1) 
A3 
(18PDs) 
A3 
(60PDs) 
A1 
(8PDs) 
B1 
(7PDs) 
Assignments 
729     Ring breathing of adenine (DNA) 
765     Pyrimidine ring breathing mode 
789     DNA backbone, -PO2- symmetric stretching 
834     Tyrosine ring breathing vibration 
858     Tyrosine Fermi resonance double with 834 
958     C-C stretching (phenylalanine) 
1054     RNA ribose C-O vibration 
1092     DNA backbone, -PO2- symmetric stretching 
1111     Benzoid ring deformation 
1155     C-C/C-N protein stretching 
1167     Isoleucine 
1245     Amide III (β-sheet, protein) 
1402     Cβ rocking (arginine) 
1450     C-H deformation vibrations 
1614     Tyrosine 
1629     Serine 
1680     Amide I, C-O vibrations of polypeptide 
backbone 
 
1 
2 
3 
4 
5 
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Table 2.  Percentage intensity decreases in selected DNA and protein bands (in bold), detected 
in Raman spectra of high proliferative/multi-potent DPSC sub-population, A3 (60PDs) and low 
proliferative/uni-potent DPSC sub-populations, A1 and B1, (8PDs and 7PDs, respectively); 
compared to high proliferative/multi-potent DPSC sub-population, A3 (18PDs). 
 
Wavenumber (cm-1) Assignments % Decreases Versus A3 (18PDs) 
729 Ring breathing of adenine 
(DNA) 
A3 (60PDs) = 6.0%; A1 (8PDs) = 
40.3%; B1 (7PDs) = 39.9% 
789 DNA backbone, -PO2- 
symmetric stretching 
A3 (60PDs) = 10.2%; A1 (8PDs) = 
46.4%; B1 (7PDs) = 31.3% 
1092 DNA backbone, -PO2- 
symmetric stretching 
A3 (60PDs) = 4.8%; A1 (8PDs) = 
30.2%; B1 (7PDs) = 21.4% 
1167 Isoleucine A3 (60PDs) = 23.6%; A1 (8PDs) = 
25.7%; B1 (7PDs) = 39.2% 
1245 Amide III (β-sheet, protein) A3 (60PDs) = 23.8%; A1 (8PDs) = 
44.2%; B1 (7PDs) = 45.4% 
1402 Cβ rocking (arginine) A3 (60PDs) = 48.3%; A1 (8PDs) = 
41.5%; B1 (7PDs) = 35.8% 
1450 C-H deformation vibrations A3 (60PDs) = 5.6%; A1 (8PDs) = 
31.0%; B1 (7PDs) = 32.2% 
1629 Serine A3 (60PDs) = 40.2%; A1 (8PDs) = 
41.1%; B1 (7PDs) = 51.0% 
1680 Amide I, C-O vibrations of 
polypeptide backbone 
A3 (60PDs) = 15.2%; A1 (8PDs) = 
40.7%; B1 (7PDs) = 39.3% 
 
 
